Page 186 - Vitamin D and Cancer

7 Induction of Differentiation in Cancer Cells by Vitamin D 173

173. Michaud NR, Therrien M, Cacace A, Edsall LC, Spiegel S, Rubin GM, Morrison DK (1997)
KSR stimulates Raf-1 activity in a kinase-independent manner. Proc Natl Acad Sci USA
94:12792–12796
174. Morrison DK (2001) KSR: a MAPK scaffold of the Ras pathway? J Cell Sci 114:1609–1612
175. Wang X, Wang TT, White JH, Studzinski GP (2006) Induction of kinase suppressor of RAS-
1(KSR-1) gene by 1, alpha25-dihydroxyvitamin D3 in human leukemia HL60 cells through
a vitamin D response element in the 5¢¢-flanking region. Oncogene 25:7078–7085
176. Garay E, Donnelly R, Wang X, Studzinski GP (2007) Resistance to 1, 25D-induced differ-
entiation in human acute myeloid leukemia HL60–40AF cells is associated with reduced
transcriptional activity and nuclear localization of the vitamin D receptor. J Cell Physiol
213:816–825
177. Gocek E, Kielbinski M, Wylob P, Kutner A, Marcinkowska E (2008) Side-chain modified
vitamin D analogs induce rapid accumulation of VDR in the cell nuclei proportionately to
their differentiation-inducing potential. Steroids 73:1359–1366
178. Wang X, Studzinski GP (2006) Raf-1 signaling is required for the later stages of 1, 25-dihy-
droxyvitamin D3-induced differentiation of HL60 cells but is not mediated by the MEK/
ERK module. J Cell Physiol 209:253–260
179. Jamshidi F, Zhang J, Harrison JS, Wang X, Studzinski GP (2008) Induction of differentiation
of human leukemia cells by combinations of COX inhibitors and 1, 25-dihydroxyvitamin D3
involves Raf1 but not Erk 1/2 signaling. Cell Cycle 7:917–924
180. Porras A, Muszynski K, Rapp UR, Santos E (1994) Dissociation between activation of Raf-1
kinase and the 42-kDa mitogen-activated protein kinase/90-kDa S6 kinase (MAPK/RSK)
cascade in the insulin/Ras pathway of adipocytic differentiation of 3T3L1 cells. J Biol Chem
269:12741–12748
181. Kuo WL, Abe M, Rhee J, Eves EM, McCarthy SA, Yan M, Templeton DJ, McMahon M,
Rosner MR (1996) Raf, but not MEK or ERK, is sufficient for differentiation of hippocampal
neuronal cells. Mol Cell Biol 16:1458–1470
182. Dhillon AS, Pollock C, Steen H, Shaw PE, Mischak H, Kolch W (2002) Cyclic AMP-
dependent kinase regulates Raf-1 kinase mainly by phosphorylation of serine 259. Mol Cell
Biol 22:3237–3246
183. Godyn JJ, Xu H, Zhang F, Kolla S, Studzinski GP (1994) A dual block to cell cycle progres-
sion in HL60 cells exposed to analogues of vitamin D3. Cell Prolif 27:37–46
184. Cicero S, Herrup K (2005) Cyclin-dependent kinase 5 is essential for neuronal cell cycle
arrest and differentiation. J Neurosci 25:9658–9668
185. Chen F, Studzinski GP (1999) Cyclin-dependent kinase 5 activity enhances monocytic phe-
notype and cell cycle traverse in 1, 25-dihydroxyvitamin D3-treated HL60 cells. Exp Cell
Res 249:422–428
186. Chen F, Rao J, Studzinski GP (2000) Specific association of increased cyclin-dependent
kinase 5 expression with monocytic lineage of differentiation of human leukemia HL60
cells. J Leukoc Biol 67:559–566
187. Tsai LH, Delalle I, Caviness VS Jr, Chae T, Harlow E (1994) p35 is a neural-specific regula-
tory subunit of cyclin-dependent kinase 5. Nature 371:419–423
188. Chen F, Studzinski GP (2001) Expression of the neuronal cyclin-dependent kinase 5 activa-
tor p35Nck5a in human monocytic cells is associated with differentiation. Blood
97:3763–3767
189. Chen F, Wang Q, Wang X, Studzinski GP (2004) Up-regulation of Egr1 by 1, 25-dihy-
droxyvitamin D3 contributes to increased expression of p35 activator of cyclin-dependent
kinase 5 and consequent onset of the terminal phase of HL60 cell differentiation. Cancer Res
64:5425–5433
190. Dudley DT, Pang L, Decker SJ, Bridges AJ, Saltiel AR (1995) A synthetic inhibitor of the
mitogen-activated protein kinase cascade. Proc Natl Acad Sci US A 92:7686–7689
191. Foster JS, Fernando RI, Ishida N, Nakayama KI, Wimalasena J (2003) Estrogens down-
regulate p27Kip1 in breast cancer cells through Skp2 and through nuclear export mediated
by the ERK pathway. J Biol Chem 278:41355–41366